# Dendreon Corporation – FDA Inspection, Nov 2, 2018

Source: https://www.keypedia.com/records/fda_inspections/dendreon-corporation/b26536bc-f097-4b4b-bee6-7f4a9ea751bd
Source feed: FDA_Inspections

> FDA inspection 1071020 of Dendreon Corporation, November 02, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1071020
- Company Name: Dendreon Corporation
- Inspection Date: 2018-11-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anita-narula/fbebf5a2-e25c-4e98-9c22-433d9102380c)
- [FDA Associated Person](https://www.keypedia.com/people/kenneth-o-gee/d61312c0-1422-4487-a5d6-ec6e76d242ee)

Company: https://www.keypedia.com/companies/dendreon-corporation/378cf699-7e31-4edf-b0f9-5ad6928ec74d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
